Organization

Anelixis Therapeutics

1 clinical trial

Clinical trial

A Phase 2a Open-Label, Multi-Center Study to Evaluate the Safety and Tolerability of Multiple Doses of AT-1501 in Adults With ALS

Status: Completed, Estimated PCD: 2022-03-24